Common name
3-(1-piperidyl)propan-1-ol
IUPAC name
3-(1-piperidyl)propan-1-ol
SMILES
OCCCN1CCCCC1
Common name
3-(1-piperidyl)propan-1-ol
IUPAC name
3-(1-piperidyl)propan-1-ol
SMILES
OCCCN1CCCCC1
INCHI
InChI=1S/C8H17NO/c10-8-4-7-9-5-2-1-3-6-9/h10H,1-8H2
FORMULA
C8H17NO
Common name
3-(1-piperidyl)propan-1-ol
IUPAC name
3-(1-piperidyl)propan-1-ol
Molecular weight
143.227
clogP
1.377
clogS
-1.219
Frequency
0.0010
HBond Acceptor
2
HBond Donor
1
Total PolarSurface Area
23.47
Number of Rings
1
Rotatable Bond
3
| Drug ID | Common name | Structure CAS | Compound class | Therapeutic area |
|---|---|---|---|---|
| FDBD00469 | Cisapride |
|
Gastrointestinal Agents; Anti-Ulcer Agents; Serotonin Receptor Agonists; Prokinetic Agents; Alimentary Tract and Metabolism; Drugs for Functional Gastrointestinal Disorders; Propulsives; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP1A2 Inducers; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C19 Inducers; Cytochrome P-450 CYP2C8 Inducers; Cytochrome P-450 CYP2B6 Inducers; Cytochrome P-450 CYP2B6 Inhibitors; CYP2A6 Inhibitors; CYP2A6 Inhibitors (strong); CYP2A6 Inhibitors (moderate); CYP2A6 Inducers; CYP2A6 Inducers (strong); CYP2B6 Inhibitors (strong); CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP3A4 Inhibitors; | For the symptomatic treatment of adult patients with nocturnal heartburn due to gastroesophageal reflux disease. |
| FDBD00672 | Biperiden |
|
Antiparkinson Agents; Muscarinic Antagonists; Parasympatholytics; Antidyskinetics; Nervous System; Anti-Parkinson Drugs; Anticholinergics; Tertiary Amines; CYP2D6 Inducers; CYP2D6 Inducers (strong); | For use as an adjunct in the therapy of all forms of parkinsonism and control of extrapyramidal disorders secondary to neuroleptic drug therapy. |
| FDBD01352 | Iloperidone |
|
Antipsychotic Agents; Adrenergic alpha-1 Receptor Antagonists; Nervous System; Psycholeptics; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP1A2 Inducers; CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP2E1 Inhibitors; CYP2E1 Inducers; CYP2E1 Inducers (strong); CYP3A4 Inhibitors; | Treatment of acute schizophrenia. |
3 ,
1
| FRAGNAME | PDBID | SIMILIRITY | XSCORE | SMILE | HAC |
|---|---|---|---|---|---|
| 2cvd_ligand_4_65.mol2 | 2cvd | 1 | -6.04 | [C@@H]1(CC[N@H+](CC1)CCC)O | 10 |
| 1aid_ligand_3_4.mol2 | 1aid | 1 | -5.57 | C([N@H+]1CC[C@H](CC1)O)CC | 10 |
| 4og6_ligand_4_30.mol2 | 4og6 | 1 | -5.57 | C(CO)C[NH+]1CCCCC1 | 10 |
| 4og8_ligand_4_35.mol2 | 4og8 | 1 | -5.55 | C([NH+]1CCCCC1)CCO | 10 |
| 2vwu_ligand_4_69.mol2 | 2vwu | 1 | -5.44 | OCCC[NH+]1CCCCC1 | 10 |
| 4l02_ligand_2_18.mol2 | 4l02 | 0.96 | -6.56 | [N@@H+]1(CC[C@@H](CC1)O)CC | 9 |
| 2cvd_ligand_3_46.mol2 | 2cvd | 0.96 | -5.97 | [C@@H]1(CC[N@H+](CC1)CC)O | 9 |
| 4jbp_ligand_2_0.mol2 | 4jbp | 0.96 | -5.56 | C1C[C@H](CC[N@@H+]1CC)O | 9 |
110 ,
12
